SEC Form 4/A · accession 0001996804-26-000011
Neurogene Inc. · NGNE
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
This is an amendment (Form 4/A). It replaces an earlier filing for the same period.
Reporting owner
Keith Woods
Director
Period of report
Jan 16, 2024
Accepted (ET)
Jun 16, 2026 · 5:32 pm EDT
Rule 10b5-1 plan
box not checked
Issuer CIK
0001404644
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy)F1 | $32.30 | Jan 16, 2024 | A | 15,400 | A | — | Jan 16, 2034 | Common Stock | 15,400 | 15,400 | D |
Explanation of responses
- F1This option represents the right to purchase 15,400 shares of common stock of the Issuer, and vests in equal monthly installments through January 16, 2027, subject to the reporting person's continued service to the Issuer through each applicable vesting date.
Remarks
This Form 4 was originally filed on January 18, 2024 using the incorrect CIK number for the Reporting Person and is being refiled under the correct CIK number. This filing amends and replaces the original filing in its entirety.